Lu Gao

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Protein Protein

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer 130 (S8) (2024)
Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer 130 (S8) (2024)
Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer (2024)
Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer 130 (S8) (2024)